Imperva, Inc.
IMPV
IMPV was delisted on the 9th of January, 2019.
130 hedge funds and large institutions have $1.17B invested in Imperva, Inc. in 2014 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 35 increasing their positions, 57 reducing their positions, and 14 closing their positions.
29% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 14
17% more capital invested
Capital invested by funds: $1B → $1.17B (+$168M)
2% more funds holding
Funds holding: 127 → 130 (+3)
14% less call options, than puts
Call options by funds: $3.48M | Put options by funds: $4.02M
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
39% less repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 57
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$62.3M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$61M |
| 3 |
O
OppenheimerFunds
New York
|
+$10.4M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.63M |
| 5 |
ACMM
Arbor Capital Management (Minnesota)
Minneapolis,
Minnesota
|
+$7.64M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$29.8M |
| 2 |
Alkeon Capital Management
New York
|
-$23.7M |
| 3 |
GP
Grow Partners
San Diego,
California
|
-$13.1M |
| 4 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$9.07M |
| 5 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
-$8.96M |
IMPV Hedge Fund Activity: Q1 2014 in Review
130 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Imperva, Inc. (IMPV) for Q1 2014, worth a combined $1.17B — up 17% from $1B a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new IMPV positions and 14 closed out — a net gain of 4 holders — while 35 added to existing stakes and 57 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $62.3M. The largest seller was JP Morgan Chase, cutting an estimated $29.8M.
- 130 institutional investors held Imperva, Inc. (IMPV) as of Q1 2014, up from 127 in Q4 2013.
- Funds reported $1.17B of Imperva, Inc. stock for Q1 2014, up 17% quarter-over-quarter.
- 18 funds opened new Imperva, Inc. positions in Q1 2014 and 14 closed out, a net change of +4 holders.
- The largest Imperva, Inc. buyer in Q1 2014 was Fidelity Investments, an estimated $62.3M added.
- The largest Imperva, Inc. seller in Q1 2014 was JP Morgan Chase, an estimated $29.8M sold.
Based on aggregated 13F filings for Q1 2014.